05/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
04/09/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
04/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
03/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
02/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
01/09/2025
|
15:00
|
Total Voting Rights
|
RNS
|
01/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
29/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
28/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
27/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
26/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
22/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
21/08/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
21/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
20/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
19/08/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
19/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
18/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
15/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
14/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
13/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
12/08/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
12/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
11/08/2025
|
07:00
|
FDA to review gonorrhea indication for gepotidacin
|
RNS
|
11/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
08/08/2025
|
07:00
|
CureVac/BioNTech mRNA patent litigation settlement
|
RNS
|
08/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
07/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
06/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
05/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
04/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
01/08/2025
|
15:00
|
Total Voting Rights
|
RNS
|
01/08/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
31/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
30/07/2025
|
07:05
|
Transaction in Own Shares
|
RNS
|
30/07/2025
|
07:00
|
2nd Quarter Results
|
RNS
|
29/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
28/07/2025
|
07:00
|
GSK enters Hengrui Pharma collaboration agreements
|
RNS
|
28/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
25/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
24/07/2025
|
17:00
|
Blenrep approved in the EU for multiple myeloma
|
RNS
|
24/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
23/07/2025
|
17:00
|
US FDA review extended for Blenrep
|
RNS
|
23/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
22/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
21/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
18/07/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
18/07/2025
|
07:00
|
Blenrep US ODAC outcome
|
RNS
|
18/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
17/07/2025
|
07:00
|
GSK’s Shingrix Fully Liquid FDA approval
|
RNS
|